TradeWorx’s Myriad Genetics MYGN Stock Holding History

TradeWorx’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-20,172	Closed	-$690K	–	419
2014 Q1	$690K	Buy	+20,172	New	+$625K	0.6%	25
2013 Q4	–	Sell	-14,682	Closed	-$345K	–	563
2013 Q3	$345K	Sell	14,682 -18,856	-56%	-$536K	0.16%	230
2013 Q2	$901K	Buy	+33,538	New	+$972K	0.39%	61

Other funds holding MYGN

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

TradeWorx's MYGN Position: Q2 2014 in Review

TradeWorx sold out of Myriad Genetics (MYGN) in Q2 2014, closing a stake of 20,172 shares — an estimated $690K sold.

TradeWorx first reported a position in MYGN in Q2 2013 and held it in 3 quarters. The position peaked at $901K in Q2 2013. 284 funds tracked by Wall St. Rank hold MYGN as of Q2 2014.

TradeWorx reported no remaining Myriad Genetics position as of Q2 2014 after selling out during the quarter.
TradeWorx sold 20,172 Myriad Genetics shares in Q2 2014, an estimated $690K.
TradeWorx first reported a position in Myriad Genetics in Q2 2013 and held it in 3 quarters.
TradeWorx's Myriad Genetics position peaked at $901K in Q2 2013.
284 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2014.

Based on TradeWorx's 13F filing for Q2 2014, filed 10 Jul 2014.